Chart Review of Antivirals for Influenza in Infants
A Retrospective Chart Review to Assess the Safety of Oseltamivir (Tamiflu®) Compared to Alternate Antiviral Therapy (Amantadine or Rimantadine) Administered to Children Less Than 12 Months of Age With Diagnosed or Suspected Influenza (CASG 113)
Study Overview
Status
Status
Conditions
Conditions
Detailed Description
Study Type
Study Type
Enrollment
Enrollment
Contacts and Locations
Study Locations
-
-
Alberta
-
Edmonton, Alberta, Canada, T6G 2B7
- University of Alberta
-
-
-
-
Alabama
-
Birmingham, Alabama, United States, 35233-0011
- University of Alabama at Birmingham
-
-
Arkansas
-
Pulaski, Arkansas, United States, 72202
- Arkansas Children's Hospital
-
-
California
-
Orange, California, United States, 92868
- Children's Hospital of Orange County
-
San Diego, California, United States, 92123
- Children's Hospital and Health Center
-
-
Colorado
-
Denver, Colorado, United States, 80218
- University of Colorado
-
-
Missouri
-
Saint Louis, Missouri, United States, 63110
- Washington University in St. Louis
-
-
Nebraska
-
Omaha, Nebraska, United States, 68198-2162
- Creighton University
-
-
Ohio
-
Cleveland, Ohio, United States, 44109
- MetroHealth Medical Center
-
-
Oregon
-
Portland, Oregon, United States, 97201-3098
- Oregon Health Sciences University
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104
- Children's Hospital of Philadelphia
-
-
Texas
-
Dallas, Texas, United States, 75390-9063
- The University of Texas Southwestern Medical Center
-
Fort Worth, Texas, United States, 76104
- Cook Children's Medical Center
-
San Antonio, Texas, United States, 78229-3900
- The University of Texas Health Science Center
-
-
Utah
-
Salt Lake City, Utah, United States, 84132
- University of Utah
-
-
Washington
-
Seattle, Washington, United States, 98105
- Seattle Children's Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Male or female study participants less than 12 months of age
- Suspected or laboratory diagnosis of influenza
- Treated with oseltamivir, rimantadine or amantadine
Exclusion Criteria:
None listed
Study Plan
How is the study designed?
Design Details
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start
Study Start
Study Completion
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 05-0111
- N01AI30025C
- CASG 113
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.